Were,
At the cap raising Progen had about the middle of last year the question was asked re one license to one company for all cancer types. Not the case. The answer given was that they would be able to issue multiple license's to either one company or several companies and the licence would be type specific ie for lung or myeloma or melanoma. You will have noticed the language they have been using recently where they talk about completeness of the data set relating to multiple cancer types. Sounds like they want to keep their options open plus embracing the maximun flexibility. Augers well in my opinion for a very good outcome.
- Forums
- ASX - By Stock
- PGL
- drug pi-88, melanoma; how good is it?
drug pi-88, melanoma; how good is it?, page-6
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PGL (ASX) to my watchlist
(20min delay)
|
|||||
Last
45.0¢ |
Change
0.005(1.12%) |
Mkt cap ! $73.30M |
Open | High | Low | Value | Volume |
44.5¢ | 45.0¢ | 44.5¢ | $88.55K | 198.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 309193 | 44.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 266671 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 309193 | 0.445 |
8 | 914031 | 0.440 |
3 | 8500 | 0.350 |
1 | 2500 | 0.200 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 266671 | 11 |
0.460 | 100000 | 1 |
0.490 | 21811 | 2 |
0.500 | 2000 | 1 |
0.590 | 292887 | 2 |
Last trade - 11.56am 24/07/2024 (20 minute delay) ? |
Featured News
PGL (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online